When GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) first became popular, investors feared it would affect...
drugmaker
Africa’s leading public health agency is in advanced talks with Aspen Pharmacare Holdings to ensure there is long-term demand for...